Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam add-on therapy in familial hypercholesterolaemia
NL-OMON31385Phase 4Not yet recruiting
- Sponsor
- Sanofi
- Start
- Jul 2007
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in familial hypercholesterolemia (FH) comparing Colesevelam add-on with Placebo add-on (2 arms). Primary endpoint: Relative reduction in LDL cholesterol at Week 6. Planned start Jul 2007; status: not yet recruiting.
02
Drugs
colesevelam
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NL-OMON31385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31385.